Press Releases

New Approach to Monitoring Changes in Cellular Structure May Lead to Early Detection of Cancerous Cells

Researchers have developed a new approach to characterizing and monitoring changes in cellular structure. The new type of single-cell-based assay, developed by researchers at Roswell Park Cancer Institute and the University at Buffalo, may provide a tool for detecting cancerous cells early and monitoring cell-to-cell variations in cancer progression or in response to pharmaceutical drugs.

Friday, October 17, 2014 - 08:00 am

News

$5.7 Million Grant Will Expand Rutgers/Roswell Park African-American Breast Cancer Study

NEW BRUNSWICK, N.J., and BUFFALO, N.Y.

Monday, October 13, 2014 - 08:00 am

News

Roswell Park Receives Special Funding Aimed at Increasing HPV Vaccinations

BUFFALO, N.Y.

Thursday, October 9, 2014 - 08:00 am

News

Roswell Park Researchers Receive Grants to Study New Anticancer Agent in Lung, Colorectal, Gastrointestinal Cancers

Researchers at Roswell Park Comprehensive Cancer Center have garnered three of four grants awarded by the National Comprehensive Cancer Network Oncology Research Program to evaluate and define the clinical effectiveness of the investigational compound nintedanib, also known as BIBF 1120. These grants were made possible through general research funding provided to NCCN from Boehringer Ingelheim Pharmaceuticals Inc.

Friday, September 26, 2014 - 08:00 am

News

Study Strengthens Evidence that Breastfeeding Can Help Prevent Aggressive Breast Cancer in African-Americans

BUFFALO, N.Y. — A large collaborative study provides new evidence that African-American women may be able to significantly reduce their risk of developing aggressive forms of breast cancer by breastfeeding.

Friday, September 19, 2014 - 08:00 am

News

Roswell Park Researchers Identify Priority Targets for Immunotherapy in Epithelial Ovarian Cancer

Researchers at Roswell Park Comprehensive Cancer Center have found that the expression pattern of a unique class of tumor-associated antigens, known as the MAGE cancer-testis antigens, correlates with clinical outcome in epithelial ovarian cancer. Based on their findings, the researchers have identified priority targets for ovarian cancer immunotherapy.

Wednesday, August 13, 2014 - 08:00 am

News

Roswell Park Comprehensive Cancer Center Researchers Review Promising Novel Approaches to MEK Inhibitor Therapy

BUFFALO, N.Y. — A review article authored by two Roswell Park Comprehensive Cancer Center experts provides a comprehensive clinical view of currently available and novel MEK inhibitors, and highlights strategies that may lead to the wider use of these agents in cancer therapy.

Wednesday, August 6, 2014 - 08:00 am

News

Roswell Park Comprehensive Cancer Center Again Included on Great Oncology Programs List

BUFFALO, N.Y. — Roswell Park Comprehensive Cancer Center has once again been included on Becker’s Hospital Review’s “100 Hospitals and Health Systems With Great Oncology Programs,” an annual list of centers that are national leaders in patient care, cancer outcomes and research.

Monday, August 4, 2014 - 08:00 am

News

Combination Nicotine Replacement Therapy Boosts Success Rate for Smokers Looking to Quit

Uninsured smokers who used nicotine replacement therapy (NRT) patches in combination with NRT lozenges nearly doubled their quit rates when using the support of a quitline, according to a study published online ahead of print in the Journal of Smoking Cessation.

Monday, July 28, 2014 - 08:00 am